{"id":11356,"date":"2020-12-04T17:08:33","date_gmt":"2020-12-04T11:38:33","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=11356"},"modified":"2025-05-06T15:14:27","modified_gmt":"2025-05-06T09:44:27","slug":"neuromodulation-devices","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/neuromodulation-devices","title":{"rendered":"Advancements in Neuromodulation"},"content":{"rendered":"\n<p>According to the International Neuromodulation Society, neuromodulation is &#8220;<em>the alteration\u2014or modulation\u2014of nerve activity by delivering electrical or pharmaceutical agents directly to a target area<\/em>&#8220;. The neuromodulation space is witnessing one of the fastest-growing medical device markets in the healthcare industry. Several big industry players such as <strong>Abbott<\/strong>, <strong>Boston Scientific<\/strong>, and <strong>Medtronic<\/strong> have developed life-changing Neuromodulation devices for many indications ranging from chronic pain to Parkinson&#8217;s disease.<\/p>\n\n\n\n<p>Neuromodulation therapies can be invasive as well as non-invasive. Examples of invasive neuromodulation therapies include cortical stimulation, deep brain stimulation (DBS), peripheral nerve stimulation, spinal cord stimulation, and vagus nerve stimulation. There also exists a broad range of&nbsp;non-invasive&nbsp;neuromodulatory devices, including electroconvulsive therapy (ECT), transcranial electrical stimulation (TES), transcranial magnetic stimulation (TMS), static magnet stimulation, and transcranial direct current stimulation (tDCS),&nbsp;among others.<\/p>\n\n\n\n<p>Deep brain stimulation (DBS) is the most common and effective form of neurostimulation treatment option for patients with advanced<a href=\"https:\/\/www.delveinsight.com\/report-store\/parkinsons-disease-market-size-analysis-treatment\" target=\"_blank\" rel=\"noreferrer noopener\"> Parkinson&#8217;s disease<\/a>.<\/p>\n\n\n\n<p>Abbott&#8217;s <strong>Infinity Deep Brain Stimulation<\/strong> (DBS) system is the US Food and Drug Administration (FDA) approved for the treatment of Parkinson&#8217;s disease. The DBS system targets a specific area of the brain known as the internal globus pallidus (GPi), critical to motor function. Stimulating the GPi improves the symptoms of Parkinson&#8217;s disease, not controlled by medication.<\/p>\n\n\n\n<p>Another type of neuromodulation is sacral neuromodulation (SNM), a minimally invasive therapy for refractory overactive bladder, non-obstructive urinary retention, and fecal incontinence. The <strong>Axonics Sacral Neuromodulation<\/strong> (SNM) System, by Axonics Modulation Technologies, is a sacral nerve stimulation system intended to treat urinary retention and the symptoms of overactive bladder. It is an implantable pulse generator (IPG) that delivers electrical pulses through a lead wire to electrodes located near the sacral nerve. The IPG sends electrical pulses to the sacral nerve that travels from the spinal cord to the bladder to improve urinary control.<\/p>\n\n\n\n<p>Though neuromodulation has been around for a while, it is just a beginning to be routinely applied as a therapy for appropriately selected patient groups. As technologies continue to develop, neuromodulation devices&#8217; demand is likely to increase dramatically.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>According to the International Neuromodulation Society, neuromodulation is &#8220;the alteration\u2014or modulation\u2014of nerve activity by delivering electrical or pharmaceutical agents directly to a target area&#8220;. The neuromodulation space is witnessing one of the fastest-growing medical device markets in the healthcare industry. Several big industry players such as Abbott, Boston Scientific, and Medtronic have developed life-changing Neuromodulation [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":11358,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[16773,16772,16775,1826,16771,16776,16770,16774],"industry":[17226,17225],"therapeutic_areas":[17245],"class_list":["post-11356","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-deep-brain-stimulation","tag-electroconvulsive-therapy","tag-neuromodulation","tag-parkinsons-disease","tag-sacral-neuromodulation","tag-transcranial-direct-current-stimulation","tag-transcranial-electrical-stimulation","tag-transcranial-magnetic-stimulation","industry-medical-devices","industry-pharmaceutical","therapeutic_areas-neurology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Advancements In Neuromodulation Devices | DelveInsight<\/title>\n<meta name=\"description\" content=\"Several big industry players such as Abbott, Boston Scientific, and Medtronic have developed life-changing Neuromodulation devices for...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/neuromodulation-devices\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Advancements In Neuromodulation Devices | DelveInsight\" \/>\n<meta property=\"og:description\" content=\"Several big industry players such as Abbott, Boston Scientific, and Medtronic have developed life-changing Neuromodulation devices for...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/neuromodulation-devices\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-04T11:38:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-06T09:44:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/12\/04142237\/Neuromodulation-Devices.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"772\" \/>\n\t<meta property=\"og:image:height\" content=\"482\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sandeep Joshi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sandeep Joshi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Advancements In Neuromodulation Devices | DelveInsight","description":"Several big industry players such as Abbott, Boston Scientific, and Medtronic have developed life-changing Neuromodulation devices for...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/neuromodulation-devices","og_locale":"en_US","og_type":"article","og_title":"Advancements In Neuromodulation Devices | DelveInsight","og_description":"Several big industry players such as Abbott, Boston Scientific, and Medtronic have developed life-changing Neuromodulation devices for...","og_url":"https:\/\/www.delveinsight.com\/blog\/neuromodulation-devices","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2020-12-04T11:38:33+00:00","article_modified_time":"2025-05-06T09:44:27+00:00","og_image":[{"width":772,"height":482,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/12\/04142237\/Neuromodulation-Devices.jpg","type":"image\/jpeg"}],"author":"Sandeep Joshi","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"Sandeep Joshi","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/neuromodulation-devices","url":"https:\/\/www.delveinsight.com\/blog\/neuromodulation-devices","name":"Advancements In Neuromodulation Devices | DelveInsight","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/neuromodulation-devices#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/neuromodulation-devices#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/12\/04142237\/Neuromodulation-Devices.jpg","datePublished":"2020-12-04T11:38:33+00:00","dateModified":"2025-05-06T09:44:27+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/f1eefd8dd4afdb0617d6166f8b301e0a"},"description":"Several big industry players such as Abbott, Boston Scientific, and Medtronic have developed life-changing Neuromodulation devices for...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/neuromodulation-devices"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/neuromodulation-devices#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/12\/04142237\/Neuromodulation-Devices.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/12\/04142237\/Neuromodulation-Devices.jpg","width":772,"height":482,"caption":"Neuromodulation Devices"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/f1eefd8dd4afdb0617d6166f8b301e0a","name":"Sandeep Joshi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7676451175fe155887a18ffb50e674b270d87436a3fc34ca206f86921cddf4cd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7676451175fe155887a18ffb50e674b270d87436a3fc34ca206f86921cddf4cd?s=96&d=mm&r=g","caption":"Sandeep Joshi"},"sameAs":["http:\/\/Delveinsight.com"]}]}},"author_meta":{"display_name":"Sandeep Joshi","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/sjoshidelveinsight-com"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/12\/04142237\/Neuromodulation-Devices-300x187.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Deep brain stimulation<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">electroconvulsive therapy<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Neuromodulation<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Parkinson\u2019s disease<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">sacral neuromodulation<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">transcranial direct current stimulation<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">transcranial electrical stimulation<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">transcranial magnetic stimulation<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Deep brain stimulation<\/span>","<span class=\"advgb-post-tax-term\">electroconvulsive therapy<\/span>","<span class=\"advgb-post-tax-term\">Neuromodulation<\/span>","<span class=\"advgb-post-tax-term\">Parkinson\u2019s disease<\/span>","<span class=\"advgb-post-tax-term\">sacral neuromodulation<\/span>","<span class=\"advgb-post-tax-term\">transcranial direct current stimulation<\/span>","<span class=\"advgb-post-tax-term\">transcranial electrical stimulation<\/span>","<span class=\"advgb-post-tax-term\">transcranial magnetic stimulation<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 5 years ago","modified":"Updated 1 year ago"},"absolute_dates":{"created":"Posted on Dec 4, 2020","modified":"Updated on May 6, 2025"},"absolute_dates_time":{"created":"Posted on Dec 4, 2020 5:08 pm","modified":"Updated on May 6, 2025 3:14 pm"},"featured_img_caption":"Neuromodulation Devices","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/11356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=11356"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/11356\/revisions"}],"predecessor-version":[{"id":31749,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/11356\/revisions\/31749"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/11358"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=11356"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=11356"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=11356"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=11356"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=11356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}